Recruiting Cancer Patients for a COVID-19 Vaccine Study
NIH has a study offering the Moderna COVID-19 vaccine for cancer patients who are either currently receiving immune- based treatment for cancer OR patients who have a blood cancer who are receiving treatment now from their doctor, and who have not yet received the COVID-19 vaccine or been infected with the virus that causes COVID-19.
Study involves:
- Physical exam and blood testing
- Two COVID-19 vaccines
- Multiple visits over a 13 month period at the NIH Clinical Center, Bethesda, MD
You may be eligible if you:
- Are at least 18 years old
- Have cancer and are either receiving immunotherapy or are being treated for a blood cancer
- Have NOT yet received the COVID-19 vaccine
- Have no history of coronavirus
The NIH Clinical Center is America's research hospital and is located in Bethesda, Maryland, on the Metro red line (Medical Center stop).
For more information:
NIH Clinical Center Office of Patient Recruitment
800-411-1222
(TTY users dial 7-1-1)
Se habla español
Email: ccopr@nih.gov
Or go online:
https://go.usa.gov/xH8S3
Refer to NIH study # 000115-C
Department of Health and Human Services
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)